158 related articles for article (PubMed ID: 6388328)
1. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
Williams RL; Clark T; Blume CD
Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
[TBL] [Abstract][Full Text] [Related]
2. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
Blume CD; Williams RL
Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
Casner PR; Dillon KR
J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of triamterene/hydrochlorothiazide combinations in mild systemic hypertension.
Schnaper HW; Maxwell MH
Am J Cardiol; 1989 Jan; 63(4):32B-36B. PubMed ID: 2643290
[TBL] [Abstract][Full Text] [Related]
7. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
Woo J; Woo KS; Kin T; Vallance-Owen J
Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial.
Maroko PR; McDevitt JT; Fox MJ; Silber SA; Young MD; Beg M; Rockhold FW; Free SM; Herron JR; Gray JM
Clin Ther; 1989; 11(1):94-119. PubMed ID: 2655909
[TBL] [Abstract][Full Text] [Related]
10. Serum magnesium and potassium levels in hypertensive patients after a therapeutic switch from hydrochlorothiazide plus a potassium supplement to maxzide.
Davidov ME; Becker FE; Hollifield JW
Am J Med; 1987 Mar; 82(3A):48-51. PubMed ID: 3565425
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension.
Backhouse CI; Rowley-Jones D; Spencer-Mills L
Curr Med Res Opin; 1986; 10(3):196-202. PubMed ID: 3731824
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE).
Amery A; Berthaux P; Birkenhäger W; Boel A; Brixko P; Bulpitt C; Clement D; Deruyttere M; de Schaepdryver A; Dollery C; Fagard R; Forette F; Henry JF; Hellemans J; Laaser U; Lund-Johansen P; MacFarlane J; Maling T; Mutsers A; Nissinen A; Ohn OH; Pelemans J; Suchettkaye AI; Tuomilehto J; Willems J
Acta Cardiol; 1978; 33(2):113-34. PubMed ID: 356497
[TBL] [Abstract][Full Text] [Related]
13. The short-term effects of reducing elevated blood pressure in elderly patients with propranolol and dyazide.
Hamdy RC; Davies A; Arnold K; Tovey JD; Saimbi SS; Short MD; Exton-Smith AN
Age Ageing; 1984 Mar; 13(2):83-8. PubMed ID: 6731169
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence study of a new tablet formulation of triamterene and hydrochlorothiazide.
Blume CD; Williams RL; Upton RA; Lin ET; Benet LZ
Am J Med; 1984 Nov; 77(5A):59-61. PubMed ID: 6496560
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of a fixed-dose combination of antihypertensive agents: an open-label surveillance study in China.
Wu Y; Hu Y; Tang X; He L; Ren T; Tao Q; Qin X; Sun N; Wang H; Cao W; Wu T; Zhan S; Wang J; Chen W; Li L
Clin Drug Investig; 2011 Nov; 31(11):769-77. PubMed ID: 21671689
[TBL] [Abstract][Full Text] [Related]
16. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
Woo J; Woo KS; Vallance-Owen J
Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
[No Abstract] [Full Text] [Related]
17. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
[TBL] [Abstract][Full Text] [Related]
18. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
[TBL] [Abstract][Full Text] [Related]
19. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide).
Hollenberg NK; Mickiewicz CW
Am J Cardiol; 1989 Jan; 63(4):37B-41B. PubMed ID: 2911994
[TBL] [Abstract][Full Text] [Related]
20. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
Douglas JG; Hollifield JW; Liddle GW
JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
[No Abstract] [Full Text] [Related]
[Next] [New Search]
